Safeguarding Public Health Through Medicines
European Medicines Agency (EMA) (europa.eu) scores 81 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Government brands, in the 75th percentile of 11275 Healthcare brands.
The European Medicines Agency (EMA) is a decentralised agency of the European Union, founded in 1995, responsible for the scientific evaluation, supervision, and safety monitoring of medicines. Operating under EU oversight, it ensures that pharmaceutical products meet safety and efficacy standards before reaching European citizens. EMA serves healthcare professionals, pharmaceutical companies, regulators, and policymakers by assessing medicines for authorization and monitoring their ongoing safety across EU member states.
| Brand Name | European Medicines Agency (EMA) |
|---|---|
| Domain | europa.eu |
| Industry | Healthcare, Government |
| Founded | 1995 |
| Parent Company / Owner | European Union |
| Main Competitors | U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Pharmaceuticals and Medical Devices Agency (PMDA) (41/100), Health Canada (83/100), World Health Organization (WHO) (93/100), Therapeutic Goods Administration (TGA) (78/100) |
Moz Domain Authority 97/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
European Medicines Agency (EMA) appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Drupal.
Social footprint: verified profiles on YouTube, LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is data.europa.eu (The European Data Portal)?", Claude could identify the brand as of August 2026. data.europa.eu is the official portal for European Union open data, aggregating datasets from EU institutions, member states, and regional and local authorities across Europe. It's run by the European Commission and serves as a central hub for finding, accessing, and reusing publ Best known for being the EU's central catalogue of open government and public sector datasets.
When asked "Best brands similar to data.europa.eu (The European Data Portal)?", Claude would recommend European Medicines Agency (EMA) as of August 2026. It's the definitive open data portal for the EU, so it would naturally come up alongside other national or supranational open data platforms.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
European Medicines Agency (EMA)'s main competitors in Healthcare: U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Pharmaceuticals and Medical Devices Agency (PMDA) (41/100), Health Canada (83/100), World Health Organization (WHO) (93/100).
Sources: Brand Analyzer scan
The European Medicines Agency (EMA) is a decentralised agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines used within the EU. It was founded in 1995 and operates as part of the EU's regulatory framework for healthcare products.
European Medicines Agency (EMA) has moderate AI-search visibility, scoring 50/100 on Brand Analyzer's AI visibility composite (visibility 35, trust 54, recommendation 71). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
European Medicines Agency (EMA) was founded in 1995. European Medicines Agency (EMA) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
EMA provides scientific evaluation and regulatory assessment services for medicines, including authorization recommendations, ongoing safety monitoring (pharmacovigilance), and supervision of pharmaceutical products for both human and animal health within the EU.
European Medicines Agency (EMA) scores 71/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
EMA is known for its role as the central EU authority overseeing the scientific evaluation and regulatory approval of medicines, ensuring that pharmaceutical products meet safety and efficacy standards before entering the European market.
As an official decentralised agency of the European Union established in 1995, EMA operates under a formal regulatory mandate to protect public and animal health through scientific evaluation and safety monitoring of medicines, which supports its credibility as an authoritative regulatory body.
European Medicines Agency (EMA) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
EMA's services and outputs are used by EU citizens, healthcare professionals, pharmaceutical companies, national regulatory bodies, and policymakers involved in the development, approval, and use of medicines within the European Union.
European Medicines Agency (EMA) is owned by or part of European Union. European Medicines Agency (EMA) operates in the Healthcare category.
Sources: Wikidata
European Medicines Agency (EMA) scores 50/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
European Medicines Agency (EMA) has a limited AI-visibility profile at 50/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (71/100) and its weakest is visibility (35/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 97/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify European Medicines Agency (EMA) from memory (August 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
81 in October 2026, down from 83 in August 2026.
Ranked closest to European Medicines Agency (EMA): Eurofarma (81/100), European Society of Cardiology (81/100), Everyone Active (81/100), Evolus (81/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.